{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-018054","form_type":"8-K","ticker":"PPCB","cik":"0001517681","company_name":"Propanc Biopharma, Inc.","filed_at":"2025-10-14T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.610881+00:00","generated_at":"2026-05-17T03:53:15.948792+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Propanc Biopharma enters Series C Preferred Stock financing with Hexstone Capital","bullets":["Issues 100 shares of Series C Preferred convertible at lesser of $5.00 fixed or 85% of lowest trading price over conversion period.","Warrant issued to purchase up to 9,900 additional Series C shares at $10,000 per warrant share.","Company reserves shares equal to 200% of maximum conversion shares; closing subject to filing Certificate of Designation with Delaware.","Transaction includes Voting Agreement with officers/directors and Registration Rights Agreement for warrant shares."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-018054","json":"https://secwatch.observer/filing/0001493152-25-018054.json","markdown":"https://secwatch.observer/filing/0001493152-25-018054.md","text":"https://secwatch.observer/filing/0001493152-25-018054.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1517681/000149315225018054/0001493152-25-018054-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1517681/000149315225018054/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T03:53:15.948792+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}